PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNoticescategoryCategories
BuyersSuppliersNoticesCategories
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Biogen IDEC Ltd
BI

Biogen IDEC Ltd

Maidenhead
Large

Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. It focuses on advancing therapies across neurology, neuropsychiatry, specialized immunology, and rare diseases.

biogen.uk.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£793.5m
Live
30
Buyers
9
12m
£688.8m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities2
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts30 / 38
  • Top buyers9
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Biogen IDEC LtdUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Biogen IDEC Ltd has won £793.5m across 9 public-sector buyers, with 30 live contracts. No active Companies House risk flags.

Why: top buyer NHS England North East and Yorkshire Health and Justice at 87% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
30 of 38Live contracts
87%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 4
Disease AreasMedicinesDiversity, Equity & InclusionClinical Trials
Frameworks & DPS · 2 from notices
  • NHS Framework Agreement - North of England - Tranche BNHS England · £17.4m
  • NHS England - Midlands and East Branded Medicines - Tranche BNHS England · £9.2m

Extracted automatically from biogen.uk.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 30 live · 8 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England North East and Yorkshire Health and Justice—01 Dec 2025£688.8m1.5 yrspending
NHS Framework Agreement for Branded Medicines - National
NHS England3360000001 May 2019£18.5m2 yrsClosed
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England3360000001 Mar 2019£9.2m2.1 yrsClosed
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England3360000001 Mar 2019£9.2m2.1 yrsClosed
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England3360000001 Mar 2019£9.2m2.1 yrsClosed
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England3360000001 Mar 2019£9.2m2.1 yrsClosed
NHS National Framework Agreement for the Supply of Adalimumab
NHS England3360000001 Dec 2018£31.9m12 moClosed
NHS Framework Agreement - North of England - Tranche B
NHS England3360000001 Mar 2018£17.4m2 yrsClosed
Cytokine Modulators
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)33600000———Live
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Procurement and Logistics Service, Business Services Organisation————Live
Total live value — · mean award £20.9m1–10 of 38

Top buyers · 9 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England North East and Yorkshire Health and Justice
1 contract
87%
since 2025
2
NHS England
15 contracts
13%
since 2018
3
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
10 contracts
0%
4
Procurement and Logistics Service, Business Services Organisation
1 contract
0%
5
eTenderwales
2 contracts
0%
6
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
3 contracts
0%
7
BELFAST HEALTH AND SOCIAL CARE TRUST
3 contracts
0%
8
Northern Health and Social Care Trust NHSCT
1 contract
0%
9
The NHS Commissioning Board (operating under the name of NHS England)
2 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire16 contracts
100%
Scotland10 contracts
0%
Northern Ireland5 contracts
0%
Wales5 contracts
0%
North West2 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Biogen IDEC Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
BI
Biogen IDEC Ltd
No£688.8m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m17
JA
Janssen-Cilag Ltd
Yes£117.6m16
AB
AbbVie Ltd
Yes£95.2m11
TA
Thornton and Ross Ltd
Yes£72.5m9
AC
ACCORD-UK LTD
Yes£71.2m18
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 09 Dec 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
01497267
Status
Active
Type
Private limited
Incorporated
19 May 1980
Reg. office
Building 5 Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UD
SIC codes
46180
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • PURWAHA, Amit Singh — director
    Appointed 14 Jul 2025
  • BROMLEY, Kylie Michele — director
    Appointed 01 Jul 2022
  • SCHMIDT, Wolfram Werner, Dr. — director
    Appointed 31 Jan 2022
  • SISAK, Neil Raymond — director
    Appointed 27 Jul 2011
  • Biogen Inc. — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
BIOGEN IDEC LIMITED
01497267 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.